Pcv48 Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence

Ridley, David B.; Axelsen, KJ

doi:10.1016/s1098-3015(10)68691-3

Value in Health

2007

DOI: 10.1016/s1098-3015(10)68691-3

|View full text |Cite

Pcv48 Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence

David B. Ridley¹,

KJ Axelsen²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

2012

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

et al. 2012

View full text Add to dashboard Cite

dertaken to better understand the factors influencing the funding decisions. RESULTS: During this period three submissions were considered under the RoR criteria, two in 2008 and one in 2009. None of these were approved for listing on the basis of the RoR, however two were accepted on the basis of high clinical need and high but acceptable cost-effectiveness ratio. No submission has requested consideration under the RoR, or been assessed under this criteria by the PBAC, since November 2009. In comparison, from 2008-2011, 4 new applications and 5 re-submissions requested listing on the LSDP and 3 of these were successful. CONCLUSIONS: Despite stricter criteria for the LSDP than the RoR, applications to the LSDP have had a better success rate. The RoR has not been used to justify a listing on the PBS for at least four years, perhaps indicating that these criteria are no longer favoured by the PBAC.

show abstract

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

et al. 2012

View full text Add to dashboard Cite

show abstract

Generic and therapeutic statin switches and disruptions in therapy

Chapman

Benner

Girase

et al. 2009

Current Medical Research and Opinion

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pcv48 Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence

Cited by 2 publications

References 0 publications

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

PHP13 Impact of Medicare Part D on Pharmaceutical and Medical Utilization in Arizona's Dual Eligible Population

Generic and therapeutic statin switches and disruptions in therapy

Contact Info

Product

Resources

About